Replies to post #545321 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

99%? Please clarify exactly what you are curious about. Are you referring to the pembrolizumab + murcidencel interim efficacy data? Those are excellent data, but I am not sure what “99%” is referring to. 100% of trial participants in both the experimental arm and the control arm are receiving murcidencel. The study has only reached its midpoint.

https://clinicaltrials.gov/ct2/show/NCT04201873






https://virtualtrials.org/webinar/